Hepatitis B Foundation

Hatch BioFund Announces New Partnership with Brandywine Realty Trust

Retrieved on: 
Wednesday, December 20, 2023

Hatch BioFund Management LLC (“Hatch BioFund”), an early- stage life sciences venture capital firm headquartered in the Philadelphia region, and Brandywine Realty Trust (“Brandywine”), one of the largest, publicly traded, full-service, integrated real estate companies in the United States, announced today a new partnership to support the advancement of life sciences companies in Greater Philadelphia.

Key Points: 
  • Hatch BioFund Management LLC (“Hatch BioFund”), an early- stage life sciences venture capital firm headquartered in the Philadelphia region, and Brandywine Realty Trust (“Brandywine”), one of the largest, publicly traded, full-service, integrated real estate companies in the United States, announced today a new partnership to support the advancement of life sciences companies in Greater Philadelphia.
  • “We are proud that Brandywine selected Hatch BioFund as its investment partner,” said Lorenzo Pellegrini, Ph.D., managing partner of Hatch BioFund.
  • “Brandywine’s platform will be invaluable in our team’s effort to support the growth of exceptional life science entrepreneurs in the Greater Philadelphia region.
  • Additionally, Philadelphia was recently named one of five regions in the country to receive a biotechnology hub designation from the Biden administration.

Foundation for Sarcoidosis Research Appoints Two New Members, Calvin Harris Jr., CPA and Joel D. Rosen, Esq., to Board of Directors

Retrieved on: 
Thursday, July 13, 2023

CHICAGO, July 13, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of Calvin Harris Jr., CPA and Joel D. Rosen, Esq.

Key Points: 
  • CHICAGO, July 13, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of Calvin Harris Jr., CPA and Joel D. Rosen, Esq.
  • "We are thrilled to welcome Calvin and Joel to the FSR Board of Directors," said Dr. Louise Perkins, FSR Board President.
  • Calvin Harris joins the FSR Board with extensive finance and accounting experience.
  • Harris was diagnosed with sarcoidosis in 2014, but despite his disease, strives to live a life in service of others.

Advancing Research, Awareness, Screening and Linkage to Care to Eliminate Hep D in the U.S. is Critical

Retrieved on: 
Tuesday, June 27, 2023

FAIRFIELD, N.J., June 27, 2023 /PRNewswire/ -- In a newly published article in the open journal, Hepatology Communications, the authors outline five urgent priority areas to address hepatitis delta (HDV)—the most aggressive form of viral hepatitis. The recommendations offered in "Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S." were the result of an American Liver Foundation and Hepatitis B Foundation joint roundtable on Hep D held in May 2022, and call on lawmakers to identify the unmet needs of this patient population and suggest strategies to better support and engage the larger community around the prevention, diagnosis, and management of hepatitis delta.

Key Points: 
  • The recommendations offered in " Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S ."
  • The five priority areas identified in the article are to generate accurate prevalence data, increase awareness, simplify screening and testing, facilitate research on linkage to care and follow-up and improve communication and outreach.
  • "It remains an enigma in the eyes of the public, healthcare providers, community groups and policy makers and that must change."
  • "This publication focuses on additional needs that must also be addressed to more optimally serve this neglected patient population."

Thermo Fisher Scientific Partners with Pennsylvania Biotechnology Center to Support Life Sciences Growth in Philadelphia

Retrieved on: 
Wednesday, September 21, 2022

The Pennsylvania Biotechnology Center (PABC) announced that Thermo Fisher Scientific has become a founding sponsor supporting the PABC campus in Doylestown, Pa., and their new B+Labs incubator in Philadelphia, where emerging life science companies can accelerate their journey to commercialization.

Key Points: 
  • The Pennsylvania Biotechnology Center (PABC) announced that Thermo Fisher Scientific has become a founding sponsor supporting the PABC campus in Doylestown, Pa., and their new B+Labs incubator in Philadelphia, where emerging life science companies can accelerate their journey to commercialization.
  • Philadelphia recently ranked as one of the top markets in the U.S. for life sciences, with continuous growth and $4B in new construction that supports the industrys expansion.
  • With more companies looking to move to Philadelphia and recent growth in the life sciences regionally, there is an urgent need for more support at early stages of development, said Louis Kassa, CEO of Hepatitis B Foundation, Blumberg Institute, Pennsylvania Biotechnology Center.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion.

Furia Rubel Communications Receives Business Achievement Award from Central Bucks Chamber of Commerce

Retrieved on: 
Wednesday, July 6, 2022

DOYLESTOWN, Pa., July 6, 2022 /PRNewswire-PRWeb/ -- Furia Rubel Communications, Inc. is thrilled to announce that the agency has been selected to receive the Business Achievement Award from the Central Bucks Chamber of Commerce. This honor is bestowed on businesses that have made a significant impact on the community of Central Bucks County in Pennsylvania.

Key Points: 
  • Integrated marketing and public relations agency honored for contributions to the business community of Central Bucks County, Pa.
    DOYLESTOWN, Pa., July 6, 2022 /PRNewswire-PRWeb/ -- Furia Rubel Communications, Inc. is thrilled to announce that the agency has been selected to receive the Business Achievement Award from the Central Bucks Chamber of Commerce .
  • This honor is bestowed on businesses that have made a significant impact on the community of Central Bucks County in Pennsylvania.
  • "We are honored to be recognized by the Central Bucks Chamber of Commerce for our contributions to the community over the past 20 years as a public relations and marketing agency," said Gina Rubel , Furia Rubel's Founder and CEO.
  • The Central Bucks Chamber of Commerce (CBCC) Achievement Awards are given annually to Bucks County organizations for achievement in the arts, hospitality, business, entrepreneurship, and humanitarian efforts.

Hepatitis D Roundtable to Address Unmet Needs of Patients

Retrieved on: 
Thursday, April 21, 2022

FAIRFIELD, N.J., April 21, 2022 /PRNewswire/ -- The American Liver Foundation (ALF) and Hepatitis B Foundation will join forces with key stakeholders concerned with identifying and addressing the unmet needs of people living with hepatitis D virus (HDV). The virtual Hepatitis D roundtable, to be held on April 21 and 22, will bring together medical experts, patients, and care partners in the hopes of finding solutions to some of the most vexing issues facing people living with HDV.

Key Points: 
  • American Liver Foundation and Hepatitis B Foundation join forces with patients, medical providers and care partners in virtual two-day event
    FAIRFIELD, N.J., April 21, 2022 /PRNewswire/ -- The American Liver Foundation (ALF) and Hepatitis B Foundation will join forces with key stakeholders concerned with identifying and addressing the unmet needs of people living with hepatitis D virus (HDV).
  • "The link between people suffering from hepatitis B and hepatitis D and liver failure has not been well understood," said Lorraine Stiehl, chief executive officer of American Liver Foundation.
  • The American Liver Foundation and Hepatitis B Foundation will jointly publish a report highlighting lessons learned from the roundtable, as a resource for people living with hepatitis D and their providers.
  • For more information about hepatitis D, visit Hepatitis Delta Connect , the Hepatitis B Foundation's program dedicated to HDV.

DiRx Partners With Hepatitis B Foundation to Offer Low-cost Medications

Retrieved on: 
Thursday, April 14, 2022

Access to proper health care for people living with hepatitis B is one of our highest priorities, and that includes helping to ensure they can afford their medications, Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, said.

Key Points: 
  • Access to proper health care for people living with hepatitis B is one of our highest priorities, and that includes helping to ensure they can afford their medications, Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, said.
  • DiRx will provide people living with hepatitis B in the U.S. with a new option for obtaining the medications they require, so we very much appreciate the companys offer to partner with our organization.
  • In addition to these critical medications for hepatitis B, DiRx carries more than 1,200 FDA-approved generic medicines with prices as low as $3 per month, including shipping.
  • About the Hepatitis B Foundation: Hepatitis B Foundation is the nations leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, and patient advocacy.

Virus-Like Particles (VLP's) Market Research Report 2021: Forecast to 2028 with COVID-19 Impact and Global Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 26, 2022

The "Virus-like Particles (VLP's) Market Forecast to 2028 - COVID-19 Impact and Global Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Virus-like Particles (VLP's) Market Forecast to 2028 - COVID-19 Impact and Global Analysis" report has been added to ResearchAndMarkets.com's offering.
  • However, the feasibility of VLPs as antigen carriers is questionable and complicated due to associated difficulties which is resulting in the sluggish growth of the global market.
  • The global virus-like particles (VLP's) market is segmented based on product type, source, and application.
  • Based on product type, the virus-like particles market is segmented as hepatitis, cancer/HPV, and Gaucher disease.

Life Science Leaders to Lease Incubator Space at B.Labs in Cira Centre

Retrieved on: 
Tuesday, November 16, 2021

PHILADELPHIA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Today, Brandywine Realty Trust (NYSE: BDN) and Pennsylvania Biotechnology Center (PABC) announced that B.Labs at Cira Centre has been 50% leased to notable life science companies.

Key Points: 
  • PHILADELPHIA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Today, Brandywine Realty Trust (NYSE: BDN) and Pennsylvania Biotechnology Center (PABC) announced that B.Labs at Cira Centre has been 50% leased to notable life science companies.
  • This new life science incubator will provide high-quality innovation, collaboration, and research space for start-up, early stage, fast-growing and established life science industry leaders.
  • Located at Cira Centre, with direct access to 30th Street Station, B.Labs offers tenants the trophy-class environment of one of the citys most architecturally celebrated buildings.
  • The momentum of University City as the destination for top life science companies is remarkable.

Dicerna Announces Poster Presentations at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021 in November

Retrieved on: 
Thursday, October 14, 2021

Both posters will be available for the duration of the meeting beginning on Friday, Nov. 12.

Key Points: 
  • Both posters will be available for the duration of the meeting beginning on Friday, Nov. 12.
  • An estimated 10% or more of adults with AAT deficiency develop clinically meaningful liver disease.2,3 People with AAT deficiency may also develop lung disease, including emphysema.
  • Dicerna is currently investigating the use of belcesiran for the treatment of AATLD in the SHINE clinical development program.
  • The Liver Meeting is a registered trademark of the American Association for the Study of Liver Diseases.